Comparison

Golimumab European Partner

Manufacturer MedChem Express
Category
Type Biosimilars
Specific against other
Amount 1mg
Item no. HY-P99111-1mg
CASRN 476181-74-5
Available
Product Description
Golimumab (CNTO-148) is a potent human IgG1 TNFα antagonist monoclonal antibody. Golimumab has anti-inflammation activitity and inhibits IL-6 and IL-1β production. Golimumab acts via targeting and neutralizing TNF to prevent inflammation and destruction of cartilage and bone. Golimumab has the anticancer activity and induces cell apoptosis. Golimumab can be used for rheumatoid arthritis, Crohn's disease and cancer research.
StorageTemperature
Please store the product under the recommended conditions in the Certificate of Analysis.
Applications
COVID-19-immunoregulation
Research Area
Cancer; Inflammation/Immunology
Target
TNF Receptor; Apoptosis; Interleukin Related; Caspase
Isoform
CD40
Pathway
Apoptosis; Immunology/Inflammation

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

Amount: 1mg
Available: In stock
available

Delivery expected until 4/20/2023 

Compare

Add to wishlist

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close